Rajiv Gandhi Centre for Biotechnology (RGCB), Department of Biotechnology, Government of India

Sphingosine 1-phosphate signaling during infection and immunity.

Mohammed S, Bindu A, Viswanathan A, Harikumar KB. (2023)

Progress in Lipid Research 92:101251.

Cardamonin Attenuates Experimental Colitis and Associated Colorectal Cancer .

James S, Aparna JS, Babu A, Paul AM, Lankadasari MB, Athira SR, Kumar SS, Vijayan Y, Namitha NN, Mohammed S, Reshmi G, Harikumar K B. (2021)

Biomolecules 11(5):661.

S1PR1 signaling in cancer: A current perspective .

Anu B, Namitha NN, Harikumar KB. (2021)

Advances in Protein Chemistry and Structural Biology 2021;125:259-274

Regulatory role of SphK1 in TLR7/9-dependent type I interferon response and autoimmunity

Mohammed S, Vineetha NS, James S, Aparna JS, Lankadasari MB, Maeda T, Ghosh A, Saha S, Li QZ, Spiegel S, Harikumar KB. (2020)

The FASEB Journal 34:4329-4347.

TAMing pancreatic cancer: combat with a double edged sword

Lankadasari MB, Mukhopadhyay P, Mohammed S, Harikumar K B(2019).

Molecular Cancer 18(1):48.
(Part of 2019 special collection "Microvesicles and tumor microenvironment in cancer development and resistance to therapies").

Examination of the role of sphingosine kinase 2 in a murine model of systemic lupus erythematosus.

Mohammed S, Vineetha NS, James S, Aparna JS, Lankadasari MB, Allegood JC, Lin QZ, Spiegel S, Harikumar KB (2019).

The FASEB Journal 33(6):7061-7071.

Targeting S1PR1/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabine.

Lankadasari MB, Aparna JS, Mohammed S, James S, Aoki K, Binu VS, Nair S, Harikumar KB (2018)

Theranostics 13;8(14):3824-3840.

See complete publication list

Harikumar K.B, PhD

Scientist E-II

Selected Publications